Negative regulation of interleukin-1-mediated signaling pathway

pathway activity — cross-omics
GO:2000660Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of interleukin-1-mediated signaling pathway pathway is significantly associated with the protein abundance of multiple proteins, with the LUAD cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are S100A12, ATF7IP_S113, and VNN2, each associated with the pathway in up to 8 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of interleukin-1-mediated signaling pathway activity versus S100A12 in LUAD (Pearson r = 0.59).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LUADS100A12 →+1.493+0.135<.001<.00138
GBMATF7IP_S113 →-0.647-0.119<.001<.00138
COADVNN2 →+1.265+0.052<.001<.00138
GBMAMPD3 →+0.583+0.154<.001<.00138
COADITGAM →+0.826+0.061<.001<.00138
GBMPGLYRP1 →+1.014+0.122<.001<.00138
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:2000660 vs S100A12 — LUAD

Per-sample scatter of Negative regulation of interleukin-1-mediated signaling pathway activity vs S100A12 in LUAD.

Explore this scatter interactively →

Exploration